Author: novacyt

Novacyt proposed admission to AIM ENG Paris, France and Cambridge, UK – 18th October 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces that it has raised a total of €9.7 million (before expenses) through a conditional placing (the “Placing”) of 7,051,590 new shares (the “Placing Shares”), raising €4.7 million, and

Novacyt Senior Hire for PrimerDesign PR Eng Paul Eros joins as Commercial Director, completing investment in the Group’s senior leadership team  

Novacyt announces largest order in China PR ENG Largest order in China for Primerdesign q16 instruments NOVAprep® demand growing